PharmaNutra revenue and financials

PHN · Borsa Italiana · EUR

Compare PharmaNutra
€86.80Change from previous close: +0.93%Absolute change: +€0.80

Close · November 17, 2026

In the fiscal year ended December 2025, PharmaNutra reported revenue of €132.16M (+13.78% year over year). Net income was €20M, a net margin of 15.1%.

Annual revenue · 2025: €132.16M
  1. €33M2016
  2. €37.79M2017
  3. €46.8M2018
  4. €53.67M2019
  5. €56.77M2020
  6. €68.14M2021
  7. €83.06M2022
  8. €100.71M2023
  9. €116.15M2024
  10. €132.16M2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+13.78%
2025 vs 2024
Net income growth
+20.44%
2025 vs 2024
Net margin
15.1%
2024: 14.3%

How PharmaNutra is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue13211610183.168.156.853.746.837.833.0
Cost of revenue65.456.952.141.136.030.330.927.322.220.3
Gross profit66.859.248.641.932.226.522.819.515.612.7
Selling, general and administrative32.726.722.517.212.19.99.57.65.85.1
Research and development0.81.31.20.5——————
Operating income29.127.423.023.118.314.212.111.28.86.2
EBIT29.127.423.023.118.314.212.111.28.86.2
EBITDA31.830.925.424.219.315.112.911.79.47.1
Interest expense0.71.10.80.10.00.00.00.10.10.1
Pre-tax income30.227.223.323.418.813.312.211.98.86.1
Income tax10.310.610.48.45.0-0.83.73.32.72.2
Net income20.016.612.815.013.814.18.58.66.03.9
Net income to common shareholders20.016.612.815.013.814.18.58.66.03.9
Basic EPS2.091.731.331.561.421.450.870.880.620.48
Diluted EPS2.091.731.331.561.421.450.870.880.620.48
Average shares (basic)9.69.69.79.79.79.79.79.79.78.1
Average shares (diluted)9.69.69.79.79.79.79.79.79.78.1
Dividend per share1.201.000.850.800.710.670.460.420.33—

Companies in the group: same industry, similar size